To confirm that the pro-invasive phenotype of ephrinB2-deficient gliomas is a direct result of ephrinB2 loss of function, we performed rescue experiments by re-introducing ephrinB2 into ephrinB2 KO tumours (Fig. 2g). This evidence concerns the gene EFNB2 and central nervous system cancer.